Related Experiment Video
Updated: Oct 21, 2025

Circumscribed Capsular Infarct Modeling Using a Photothrombotic Technique
Published on: June 2, 2016
Capsular Warning Syndrome - A Case Series and Discussion on Management Dilemmas
Uma Sundar1, Pramod Darole2, Ashank Bansal3
1Professor, Medicine, LTMMCH, Mumbai, Maharashtra; Corresponding Author.
Capsular warning syndrome (CWS) involves recurrent, stereotypical transient ischemic attacks. Intravenous thrombolysis appears safe and effective for CWS, similar to acute ischemic stroke, followed by antiplatelet therapy.
Area of Science:
- Neurology
- Cerebrovascular Diseases
Background:
- Capsular warning syndrome (CWS) is characterized by recurrent, stereotypical transient ischemic attacks without cortical signs.
- A significant percentage of CWS patients develop infarcts, yet treatment guidelines are lacking.
- CWS is a lesser-known neurological entity requiring further investigation.
Purpose of the Study:
- To investigate the clinical characteristics, management, and outcomes of patients with suspected Capsular warning syndrome (CWS).
- To evaluate the safety and efficacy of intravenous thrombolysis in CWS patients.
- To contribute to the understanding and potential treatment strategies for CWS.
Main Methods:
- Retrospective study of 9 patients presenting with recurrent, stereotypical transient ischemic attacks suggestive of CWS over two years.
- Analysis of clinical data, neuroimaging (CT brain angiography), etiological investigations, management, and patient outcomes.
- Inclusion of patients who received intravenous thrombolysis with t-PA.
Main Results:
- Seven out of nine patients were under 40 years old, with pure motor syndrome being the most common presentation.
- Neurologic deficits ranged from 5 to 20 minutes with complete recovery between episodes.
- Five patients received IV thrombolysis; one worsened, while four improved clinically.
Conclusions:
- The pathogenesis and management of CWS remain unclear, posing a treatment dilemma.
- Intravenous thrombolysis may be a safe option for CWS, similar to acute ischemic stroke.
- Antiplatelet agents are recommended following thrombolysis for CWS patients.
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Endocarditis III: Medical Management
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Acute Pancreatitis II: Clinical Manifestations and Management

